Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

On the correlation of cereblon binding, fluorination and antiangiogenic properties of immunomodulatory drugs

Biochemical and Biophysical Research Communications(2020)10.1016/j.bbrc.2020.11.117Source: DataRank Database

On the correlation of cereblon binding, fluorination and antiangiogenic properties of immunomodulatory drugs is a research paper published in Biochemical and Biophysical Research Communications (2020). On theSindex it has a DataRank of 0. It has been cited 18 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access18 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 0.90)OA: hybridTopics (51)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Samuel Maiwald ORCID,Christian Steinebach ORCID,Matthew K. Collins ORCID,Jonathan D. Strope ORCID,Cindy H. Chau ORCID

Live enrichment

PubMed:33310190 PMC:PMC7815984 OpenAlex:https://openalex.org/W3113113983

Intramural NIH HHS

Grant: ZIA SC006538

Max-Planck-Gesellschaft

National Cancer Institute

FWCI

0.90

Citation Percentile

0.7%

Citation Trend

2022

2023

2024

2025

2026

hybridLicense: cc-by

journalhttps://www.sciencedirect.com/science/article/pii/S0006291X20321616/pdf

publisherhttps://www.sciencedirect.com/science/article/pii/S0006291X20321616/pdf

publisherhttps://api.elsevier.com/content/article/PII:S0006291X20321616?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0006291X20321616?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.bbrc.2020.11.117

Fields of Study

Protein Degradation and InhibitorsMultiple Myeloma Research and TreatmentsUbiquitin and proteasome pathwaysAdaptor Proteins, Signal TransducingAngiogenesis InhibitorsAnimalsAortaDrug Evaluation, PreclinicalHalogenationHuman Umbilical Vein Endothelial CellsHumansImmunologic FactorsMaleRats, Sprague-DawleyStructure-Activity RelationshipThalidomideUbiquitin-Protein LigasesRats

MeSH Terms

AnimalsAortaDrug Evaluation, PreclinicalHumansImmunologic FactorsMaleStructure-Activity RelationshipThalidomideRats, Sprague-DawleyAngiogenesis InhibitorsUbiquitin-Protein LigasesAdaptor Proteins, Signal TransducingRatsHalogenationHuman Umbilical Vein Endothelial Cells

Keywords

CereblonThalidomideUbiquitin ligaseChemistryIn vitroReceptorPharmacologyCancer researchUbiquitinBiochemistryBiologyImmunologyMultiple myelomaCancer therapyMstCrbnImidsMicroscale Thermophoresis

Sustainable Development Goals

SDG 0: Good health and well-being